TH
AZN icon

Timber Hill’s AstraZeneca AZN Stock Holding History

Timber Hill’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-89,000
Closed -$5.54M – 1002
2017
Q1 		$5.54M Buy
89,000
+43,700
+96% +$2.54M 0.04% 302
2016
Q4 		$2.48M Buy
45,300
+7,650
+20% +$434K 0.01% 796
2016
Q3 		$2.47M Sell
37,650
-65,400
-63% -$4.27M 0.01% 720
2016
Q2 		$6.22M Buy
103,050
+72,100
+233% +$4.19M 0.03% 456
2016
Q1 		$1.74M Buy
30,950
+5,900
+24% +$355K 0.01% 1005
2015
Q4 		$1.7M Sell
25,050
-84,150
-77% -$5.52M 0.01% 1058
2015
Q3 		$6.95M Sell
109,200
-135,900
-55% -$8.94M 0.03% 435
2015
Q2 		$15.6M Buy
245,100
+117,600
+92% +$8.05M 0.07% 245
2015
Q1 		$8.72M Buy
127,500
+56,300
+79% +$3.91M 0.04% 374
2014
Q4 		$5.01M Sell
71,200
-1,100
-2% -$78.8K 0.02% 564
2014
Q3 		$5.17M Sell
72,300
-40,600
-36% -$2.97M 0.02% 600
2014
Q2 		$8.39M Buy
112,900
+75,700
+203% +$5.47M 0.04% 395
2014
Q1 		$2.41M Sell
37,200
-1,400
-4% -$90.4K 0.01% 1051
2013
Q4 		$2.29M Sell
38,600
-57,500
-60% -$3.12M 0.01% 1284
2013
Q3 		$4.99M Sell
96,100
-147,600
-61% -$7.41M 0.02% 848
2013
Q2 		$11.5M Buy
+243,700
New +$12.4M 0.04% 378

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Timber Hill's AZN Position: Q4 2017 in Review

Timber Hill sold out of AstraZeneca (AZN) in Q4 2017, closing a stake of 3,956 shares — an estimated $268K sold.

Timber Hill first reported a position in AZN in Q3 2013 and held it in 14 quarters. The position peaked at $6.32M in Q2 2014. 503 funds tracked by Wall St. Rank hold AZN as of Q4 2017.

  • Timber Hill reported no remaining AstraZeneca position as of Q4 2017 after selling out during the quarter.
  • Timber Hill sold 3,956 AstraZeneca shares in Q4 2017, an estimated $268K.
  • Timber Hill first reported a position in AstraZeneca in Q3 2013 and held it in 14 quarters.
  • Timber Hill's AstraZeneca position peaked at $6.32M in Q2 2014.
  • 503 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2017.

Based on Timber Hill's 13F filing for Q4 2017, filed 9 Feb 2018.